Written question asked by Steve Barclay (Conservative) on Tuesday, 16 June 2026, in the House of Commons. It was due for an answer on Thursday, 18 June 2026. It was answered by Kanishka Narayan (Labour) on Wednesday, 24 June 2026 on behalf of the Department for Science, Innovation and Technology.
Life Sciences Innovative Manufacturing Fund: Advanced Therapy Medicinal Products
- Question
-
To ask the Secretary of State for Science, Innovation and Technology, how much funding through the Life Sciences Innovative Manufacturing Fund has been awarded to projects focused on Advanced Therapy Medicinal Products (ATMPs).
- Answer
-
The Government has committed up to £520m for life sciences manufacturing, through the Life Sciences Innovative Manufacturing Fund (LSIMF). The scheme launched in October 2024 and will deliver funding until March 2030. Projects focused on Advanced Therapy Medicinal Products (ATMPs) are in scope of the scheme, and we have supported two projects in this sector, totalling £4,335,478 of grant funding. We have other ATMP projects in the pipeline, and expect to make further grant awards soon. We continue to welcome applications from the ATMP sector.
Secondary information
- Type
- Written question
- Reference
- 10111
- Session
- 2026-27
- Subjects
- Advanced therapy medicinal products Life Sciences Innovative Manufacturing Fund
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-06-24 17:46:36 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/10111
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/10111
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/10111